Investing in Psychedelics

The conversation highlights the growing interest in psychedelic therapy and its potential benefits, paralleling its rise to that of alcohol before Prohibition. While many companies in this space are still in the R&D phase without earnings, there’s a belief that investing in a diversified portfolio of these stocks could lead to significant returns. Caution is advised, but the potential for substantial gains makes it an area worth exploring.